Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

PPJ Healthcare Enterprises, Inc.

A Florida Corporation

401 E. Jackson Street, Suite 2340 Tampa, FL 33602

Phone (813) 723-1206 , Fax (866) 622-3215

Email:info@ppjenterprise.com

website:www.ppjenterprise.comSIC Code: 7389 - Business services, misc.

FOR THE PERIOD ENDING JUNE 30, 2022

OTC Markets Symbol: PPJE

As of June 30, 2022, the number of shares outstanding of our Common Stock was: 5,305,836,058

As of December 31, 2021, the number of shares outstanding of our Common Stock was 5,305,836,058

As of December 31, 2020,the number of shares outstanding of our Common Stock was: 4,840,836,058

Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of

1933 and Rule 12b-2 of the Exchange Act of 1934):

Yes:

No:

Indicate by a check mark whether the company's shell status has changed since the previous reporting period:

Yes:

No:

Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:

Yes:

No:

  1. Name and address(es) of the issuer and its predecessors (if any)

PPJ Healthcare Enterprises, Inc.("PPJE") formerly PPJ Enterprise until November 2014, formerly Healthcare Business Services Groups, Inc. (Nevada) until April 2008, formerly Winfield Financial Group, Inc. until December 2005, formerly Winfield Capital Group, Inc. Until March 2004.

In answering this item, please also provide any names used by predecessor entities and the dates of the name changes.

The state of incorporation or registration of the issuer and each of its predecessors (if any) during the past five years. Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 1

Florida. PPJE's current standing is active.

.

Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:

No.

If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:

List of any stock split, stock dividend, recapitalization, merger, acquisition, spin off or reorganization ether currently anticipated or that occurred within the past 12 months:

No.

The address (es) of the issuer's principal executive office:

401 East Jackson Street, suite 2340, Tampa, FL 33602.

The address(es) of the principal place of business:

Check box if principal executive office and principal place of business are the same address:

Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?

Yes:

No:

If the issuer or any of its predecessors have been the subject of such proceeding, please provide additional details in the space below:

2)

Security Information

Trading symbol:

PPJE

Exact title and class of securities outstanding:

Common Stocks

CUSIP:

No. 35369D505

Par or stated value:

.0001

Total shares authorized:

8,000,000,000 as of date: 6/30/2022

Total shares outstanding:

5,305,836,058 as of date: 6/30/2022

Number of shares in the Public Float2:

4,660,836,058 as of date: 6/30/2022

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 2

Total number of shareholders of record:

119

as of date: 6/30/2022

Class A Preferred Stocks

CUSIP:

No. 35369D505

Par or Stated value:

$10.00

Total shares authorized: Total

5,000,000

as of date: 6/30/2022

shares issued:

0

as of date: 6/30/2022

Total shares outstanding:

0

as of date: 6/30/2022

Number of shares in the Public Float

0

as of date: 6/30/2022

Class B Preferred Stocks

CUSIP:

No. 35369D505

Par or Stated value:

$2.50

Total shares authorized:

50,000,000

as of date: 6/30/2022

Total shares issued:

2,118,000

as of date: 6/30/2022

Total shares outstanding:

0

as of date: 6/30/2022

Number of shares in the Public Float

0

as of date: 6/30/2022

Total number of shareholders of record:

5

as of date: 6/30/2022

Number of shares in the Public Float

0

as of date: 6/30/2022

Class E Preferred Stocks

CUSIP:

No. 35369D505

Par or stated value:

.01

Total shares authorized:

100,000,000

as of date: 6/30/2022

Total shares outstanding:

40,005,000

as of date: 6/30/2022

Number of shares in the Public Float3:

0

as of date: 6/30/2022

Number of shares in the Public Float

0

as of date: 6/30/2022

Non-Dilutive Common Stock

CUSIP:

No. 35369D505

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 3

Par or stated value:

.0001

Total shares authorized:

8,000,000,000

as of date: 6/30/2022

Total shares outstanding:

0

as of date: 6/30/2022

Number of shares in the Public Float4:

0

as of date:6/30/2022

All additional class(es) of publicly traded securities (if any): None

Transfer Agent

Vstock Transfer, LLC 18 Lafayette Place Woodmere, New York 11598 Phone: (212) 828- 8436 Ext. 124 www.VstockTransfer.comemail: shaindy@VstockTrsndfer.c om

Is the Transfer Agent registered under the Exchange Act?5 Yes: No:

  1. Issuance History

The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.

Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.

A. Changes to the Number of Outstanding Shares

Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods:

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 4

Shares Outstanding as of Second Most

Recent Fiscal Year End:

Opening Balance

Date 12/31/2021

Common:

4,840,836,058

CLASS B Preferred: 2,118,000 Class E

Preferred 40,005,000

Date of

Transaction

Number of

Class of

Value of

Were the

Individual/

Reason for

Restricted

Exe

Entity

share

or

Transaction

type (e.g.

Shares

Securities

shares

shares

Shares were

issuance (e.g.

or

new

Issued

for

Unrestricted

issuance,

(or canceled)

issued

issued

issued to

cash or debt

as of this

Reg

cancellation,

($/per

at a

(Entities

conversion)

filing.

Typ

must

shares

share) at

discount

have

-OR-

t

individual

returned to

Issuance

to

with voting /

Nature of

treasury)

market

investment

Services

price at

control

Provided

the time

disclosed).

of

issuance?

(Yes/No

)

2/25/2019

Returned to

3,400,000,000

Common

$334,000

No

Chandana

Lawsuit

Restricted

Non

Treasury

Basu

Liability

es

2/28/2019

Issuance

400,000,000

Common

$4,000

Yes

GPL

Illegal

Unrestricted

Sect

Ventures

Conversion

3(a)(

c/o Mr.

the

Cosmin

Secu

Panait

Act

No

Chandana

Lawsuit

3/31/2019

Issuance

30,000,000

Class E

$300,000

Basu

expenses

Restricted

Non

Preferred

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

PPJ Healthcare Enterprises Inc. published this content on 09 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 August 2022 17:58:14 UTC.